Vitiligo Clinical Trial: Segmental Study
Vitiligo Clinical Trail: Segmental Study
Study to Identify the Autoimmune Mechanism
Behind Segmental Vitiligo
|UMass Dept. of Dermatology
55 N. Lake Ave
Worcester, MA 01655
|Henry Ford Dept. of Dermatology
3031 West Grand Boulevard
Detroit, MI 48202
Scientists from three United States academic centers are collaborating to identify how and why the immune system initiates an autoimmune attack against specific pigment cells in segmental vitiligo. By understanding why this happens, new treatments targeting this process can be designed.
In segmental vitiligo, pigment cells on one side and area of the body are destroyed leaving a white area behind. One theory as to why this specific area loses its pigment cells is the pigment cells in segmental vitiligo may express different proteins from other pigment and non-pigment cells in the body. In order to identify these differences, a thin piece of repigmented (regain of color) vitiligo skin and sample of blood is needed.
Your participation is vitally needed
Ages: 7-89 years of age
Diagnosis of segmental vitiligo
At least 1 spot of repigmentation (regain of color) within the segmental vitiligo
Exclusion Criteria: The following will not be eligible:
Diagnosis of generalized vitiligo
What will happen if I participate?
A small amount of blood will be collected in the same manner as blood drawn at your regular doctor’s office.
A superficial piece of tissue (shave biopsy) will be taken from the area of segmental vitiligo. Shave biopsies are a common procedure performed at dermatology offices.
Phone: 313-916-6964 or Email: email@example.com